FTC Approves Amended Final Order Settling Charges that Teva's Proposed Acquisition of Cephalon was Anticompetitive in Markets for Several Generic Drugs
Date
Following a public comment period, the Federal Trade Commission has approved an amended final order settling charges that Teva Pharmaceutical Industries, Ltd.'s proposed acquisition of rival Cephalon...